MEDINET CO
Cancer immuno-cell therapy is an advanced medical practice, which requires advanced knowledge in biotechnology and molecular genetics, specific technical know-how, professional cell-engineers, dedicated-use facilities with advanced safety control, particular materials and a custom-made management system for cell-culturing schedule. However, it is difficult for medical institutions to meet all of these requirements on the financial and technical aspects, and only limited numbers of medical instit... utions, such as university hospitals, are able to fulfill such requirements. Such limited numbers of medical institutions perform the immuno-cell therapy to limited number of patients for research purpose only. Therefore, it seemed that the immuno-cell therapy had not been widely used in clinical practice. In order to make the immuno-cell therapy widely available to anyone who wish to receive, MEDINET created and started providing a comprehensive solution, which includes technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy, to medical institutions.
MEDINET CO
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1995-01-01
Address:
Kahoku, Miyagi, Japan
Country:
Japan
Website Url:
http://www.medinet-inc.co.jp
Total Employee:
51+
Status:
Active
Contact:
+81454780041
Total Funding:
511.49 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Mobile Non Scaleable Content Euro Cloudflare JS CDN JS
Similar Organizations
Advanced Immunotherapy
Advanced Immunotherapy is developing cancer immunotherapy using T-iPS cells.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Stock Details
Investors List
Whiz Partners
Whiz Partners investment in Post-IPO Equity - Medinet Co
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-02-01 | REGiMMUNE | Medinet Co investment in Series C - REGiMMUNE | 5 M USD |
| 2008-09-30 | Reprocell Japan | Medinet Co investment in Corporate Round - Reprocell Japan | 21 M JPY |
Official Site Inspections
http://www.medinet-inc.co.jp Semrush global rank: 1.15 M Semrush visits lastest month: 27.61 K
- Host name: de.ptr153.ptrcloud.net
- IP address: 153.122.81.210
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Medinet Co"
MEDINET | HOME
MEDINET is your ideal choice for contract manufacture under the new Japanese regulatory framework for regenerative medicine. Our experienced specialists with expertise in the new โฆSee details»
MEDINET | About Us - medinet-inc.co.jp
MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the entire regenerative โฆSee details»
MEDINET | About Us | Corporate Profile
Oct 17, 1995ย ยท MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the โฆSee details»
MEDINET (MEDINET Co., Ltd.) | ๅบไบ็็ฉ็งๆ่กไปฝๆ้ๅ ฌ โฆ
The Medinet Co., Ltd. was established in October 1995, and was successfully commercialized the immune cell therapy technology in 1999 and became the first biotechnology company to โฆSee details»
MEDINET Co., Ltd. (TYO: 2370) Company Profile & Overview
Oct 7, 2024ย ยท Company profile for MEDINET Co., Ltd. (TYO: 2370) with a description, list of executives, contact details and other key facts.See details»
Medinet Company Profile 2024: Stock Performance & Earnings
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical โฆSee details»
MEDINET Co., Ltd. - Shared Research
Website: https://www.medinet-inc.co.jp/english/ir/ Summary Shifting from Immuno-Cell Therapy Total Support Service to the Contracted Cell Manufacturing Business; sale and development โฆSee details»
MEDINET Co., Ltd. - CMOCRO - Domain Name
Private/Public: public Phone: +81-3-6631-1201 Fax: +81-3-6631-1202 Website: http://www.medinet-inc.co.jp/english/ Address: TRC Center Bldg. 9F, 6-1-1 Heiwajima, Ota-ku, โฆSee details»
MEDINET Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024ย ยท MEDINET is a contract development and manufacturing organization (CDMO) focused on the cancer immuno-cell therapy. It offers solutions for the regenerative medicine โฆSee details»
MEDINET | Investors
MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the entire regenerative โฆSee details»
MEDINET | Why MEDINET - medinet-inc.co.jp
MEDINET offers the specialized technology and expertise required to manage cell processing facilities for immuno-cell therapy. We provide personnel for cell processing and culturing, โฆSee details»
Medinet Co - Crunchbase Company Profile & Funding
Medinet Co is located in Kahoku, Miyagi, Japan. Who invested in Medinet Co? Medinet Co is funded by Whiz Partners. How much funding has Medinet Co raised to date? Medinet Co has โฆSee details»
Medinet - Crunchbase Company Profile & Funding
Medinet is a health tech company that offers a suite of Telehealth products that brings lifelong health and well-being. The MyPractice app from Medinet enables GPs to consult with their โฆSee details»
PharmaNet and Medinet Full Service Billing | Medinet
Medinet welcomes Physicians, Dentists, Nurse Practitioners, Pharmacists, Midwives, and Administrators to the PharmaNet Family! Support: (604) 737-1477 | 1 (800) 737-3771 HomeSee details»
MEDINET | About Us | History - medinet-inc.co.jp
MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the entire regenerative โฆSee details»
Medigen collaborates with Japanese company MEDINET | ๅบไบ็ โฆ
Oct 7, 2019ย ยท Medigen announces that it has entered into exclusive license agreement with Japanese publicly listed company MEDINET today (2019/10/07), under which Medigen โฆSee details»
MEDINET | About Immuno-Cel Therapy - medinet-inc.co.jp
Immuno-cell therapy is classified as a cell therapy as well as a regenerative medicine represented by cultured skin and cartilage, and stem cell transplant, and includes various types of immuno โฆSee details»
MEDINET | About New Japanese Regulatory framework
Japanโs new framework is welcomed by entities developing medical technologies using processed cells as well as enterprises seeking to develop and commercialize regenerative medical โฆSee details»
MEDINET | Investors | Financial Report
MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the entire regenerative โฆSee details»
MEDINET | Facility/ Capabilities
MEDINET is the most experienced cell-processing enterprise and well-known CDMO, Contract Development and Manufacturing Organization, offering solutions for the entire regenerative โฆSee details»